Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
-
Young Bettors and March Madness Participants Face High Gambling Risks
-
BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings
-
Beyond Identity and Nametag Announce Strategic Partnership to Strengthen Identity & Access Management Using Deepfake Defense™ Identity Verification
-
PubMatic’s Connect Platform for Curation Delivers for Publishers: Drives 25%+ Higher eCPMs, Incremental Revenue and Diverse Demand
-
First Responders Children's Foundation Announces Chief Theresa Tobin as Chief National Public Safety Liaison
-
Reflect Scientific Inc. Reports Strong Revenue Growth in 2024
-
Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology
-
LiveOne (NASDAQ: LVO) Exceeds 1.3M Subscribers and Ad-Supported Users, Including Tesla
-
Pathos AI Doses First Patient in Phase 1b/2a Clinical Trial of Pocenbrodib, a CBP/p300 Inhibitor
-
Founder Group Secures Contract Valued at US$2.6 Million to Build a Roof-Top Solar Generating Facility in Malaysia
-
Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
-
Academy Sports + Outdoors Reports Fourth Quarter and Fiscal 2024 Results
-
REPEAT: Rocket Doctor Scales Rapidly in Alberta, Strengthening Physician Independence and Expanding Healthcare Access
-
Candel Therapeutics and IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409
-
Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the European Lung Cancer Congress 2025
-
KICK Announces KICK Partner Fast Track Program with OTK Subsidiary Cross Realm Inc.
-
BriteCore Named “Best P&C InsurTech Solution” in 9th Annual FinTech Breakthrough Awards Program
-
NevGold Increases the Size of the Zeus Copper Project by Approximately 50% Or 1,000 Hectares in the Hercules Copper District, Idaho
-
Steve Madden Partners with RunDTC & Contentstack for eCommerce Transformation on Shopify
-
Teledyne’s new 2.5 GigE Vision line scan camera delivers industry-leading performance in a cost-effective package
-
Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction
-
Nitrase Therapeutics Unveils Protein with Newly Characterized Enzymatic Function Involved in the Pathogenesis of Parkinson’s Disease
-
Axonius Unveils Unified Identity Management & Security Solution to Centralize IAM Program Operations
-
Esperion Aligns with U.S. Food and Drug Administration to Initiate Phase 3 Clinical Trials of Bempedoic Acid in Pediatric Heterozygous and Homozygous Familial Hypercholesterolemia
-
Yara refinances revolving credit facility with 11 banks
-
Resolutions taken by the Annual General Meeting of SATO Corporation
-
Transfer of Huhtamäki Oyj's own treasury shares
-
Endeavour Announces Renewal of Normal Course Issuer Bid
-
ECD Auto Design Now Accepting Cryptocurrency Payments via BitPay
-
$MUBARAK and $MUBARAKAH Now Available for Trading on BYDFi
-
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
-
Alm. Brand A/S – Candidates for the Board of Directors 2025
-
Alm. Brand A/S – Chairman Jørgen Hesselbjerg Mikkelsen will not be standing for re-election at upcoming annual general meeting
-
Alarum Technologies Announces Fourth Quarter and Annual 2024 Results
-
Duke Robotics Reports 2024 Financial Results and Provides Business Update
-
Revival Gold Enters Marketing Services Agreement
-
Antitrust and Industrial Organization Expert Matthew Backus Affiliates with Compass Lexecon
-
Knight Therapeutics Reports Fourth Quarter and Year-End 2024 Results
-
Aqua-Tots Dives Deeper into New Jersey with Fifth Location Coming Mid-April to North Bergen
-
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
-
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
-
Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
-
Highwire Achieves Double-Digit Growth in 2024, Elevates Michael Byrnes to Chief Growth Officer
-
Nayax Introduces Innovative State-of-Charge Feature for EV Kiosk, Elevating EV Charging Experience
-
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
-
3 E Network Technology Group Limited Announces Strategic Equity Investment in HashBeaver to Accelerate Blockchain Innovation
-
Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
-
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
-
XOMA Royalty Declares Quarterly Preferred Stock Dividends
